Axelyf, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
through Oct 13, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Aug 7, 2025 · D | Oct 13, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $6,342,133 | $2,700,000 | $-3,642,133 |
| Reported amount sold | $4,842,133 | $2,631,439 | $-2,210,694 |
| Reported investor count | — | 8 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001437749-25-025327 · Later SEC source: 0001437749-26-032509
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $2,700,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $2,631,439
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Form D filings (2)
-
0001437749-26-032509D · Oct 13, 2026 · BiotechnologyOffering: $2,700,000Sold: $2,631,439
Compared with 0001437749-25-025327:
- Reported offering amount: $6,342,133 → $2,700,000
- Reported amount sold: $4,842,133 → $2,631,439
- Reported investor count: Unavailable → 8
-
0001437749-25-025327D · Aug 7, 2025 · BiotechnologyOffering: $6,342,133Sold: $4,842,133